A reconfigurable "body-on-a-chip" model could transform drug development by simultaneously measuring compound efficacy and toxicity, for both target cells and other organs, such as the heart and liver. These findings, published ...
Jun 19, 2019
0
22
For the first time, a major study suggests that an experimental drug works against the new coronavirus, and U.S. government officials said Wednesday that they would work to make it available to appropriate patients as quickly ...
Apr 29, 2020
1
30
Any drug that is taken orally must pass through the lining of the digestive tract. Transporter proteins found on cells that line the GI tract help with this process, but for many drugs, it's not known which of those transporters ...
Feb 20, 2024
0
64
Robert Greenberg got tired of hearing from senior engineers that it wasn't possible to build his product idea: a bionic eye that gives sight to the blind. "A lot of the folks straight out of school didn't know any better, ...
May 6, 2013
1
0
A quarter-century after the U.S. Food and Drug Administration approved the first prescription drugs based on the main psychoactive ingredient in marijuana, additional medicines derived from or inspired by the cannabis plant ...
Jan 23, 2012
0
0
Supporters and producers of organic foods petitioned the US government Tuesday for mandatory labeling of genetically engineered foods, and encouraged consumers to go online and join the cause.
Oct 5, 2011
1
0
While an undergraduate in biochemistry at McMaster, Michelle Fernandes worked as a researcher for a biotech company. Now a master's candidate in chemical engineering, she credits that co-op work experience with sparking her ...
Jun 28, 2013
1
0
(AP) -- The Food and Drug Administration is preparing to review the first lower-cost versions of biotech drugs, expensive medications which have never before faced generic competition.
Feb 9, 2012
1
0
After years of disappointing studies of potential treatments for the more than 6 million people living with Alzheimer's disease, the U.S. Food and Drug Administration recently approved a new drug called aducanumab that is ...
Jun 9, 2021
0
3
A US jury has ordered pharmaceutical giant Gilead Sciences to pay $2.5 billion to competitor Merck in a patent infringement case involving a drug used to treat hepatitis C, the two companies said.
Dec 16, 2016
0
0
